Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 23 Fallopian Tube Neoplasms 7 Carcinoma, Ovarian Epithelial 6 Platinum-resistant Recurrent Ovarian Cancer 2 Ovarian Cancer Recurrent 2 Melanoma 2 Colorectal Neoplasms 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Platinum-resistant Ovarian Cancer 1 Peritoneal Neoplasms 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Esophageal Squamous Cell Carcinoma 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Advanced Ovarian Cancer 1

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × 1-dodecylpyridoxal × Gynecologic × Clear all

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡